Merger of Dutch

Merger of Dutch biotechnology companies IntroGene and U-BiSys, to form Crucell, and subsequent IPO. Financial adviser Goldman Sachs represented by Linklaters & Alliance (Paul Cronheim). Crucell advised by Allen & Overy, Cleary Gottlieb Steen & Hamilton and Loyens & Loeff. Underwriters Goldman Sachs, ING Bank and UBS Warburg advised by Linklaters (Bill Hobbs and Stephen Blackshaw).